PREVENTion and treatment of Incontinence-Associated Dermatitis (IAD) through optimising care: development and feasibility cluster randomised trial of the IAD-Manual (PREVENT-IAD)

This is a Pre-Registered Trial study.

Key Points

The trial tests a treatment for incontinence-associated dermatitis, aiming to improve care standards.
Incontinence-associated dermatitis may lead to significant discomfort and complications in affected individuals.
Cluster randomised trial for developmental intervention indicates practical strategies for managing skin health.
Effective management can help lessen the incidence of skin conditions linked to incontinence, benefiting patient care.

Cluster randomised trial tests treatment plan for incontinence-associated dermatitis, suggesting effective care methods may reduce incidence.

This trial was prospectively registered on 07/02/2020 (intervention development) ISRCTN26169429 and 28/02/2024 (feasibility study) ISRCTN70866724.

No takes yet. Share an insight, caveat, or question.

Woodward et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Share